Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells (PLoS ONE (2017) 12: 4 (e0176139) DOI: 10.1371/journal.pone.0176139)

Anup Sharma; Rajita Vatapalli; Eihab Abdelfatah; Kevin Wyatt McMahon; Zachary Kerner; Angela A. Guzzetta; Jasvinder Singh; Cynthia Zahnow; Stephen B. Baylin; Sashidhar Yerram; Yue Hu; Nilofer Azad; Nita Ahuja

doi:10.1371/journal.pone.0242750

Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells (PLoS ONE (2017) 12: 4 (e0176139) DOI: 10.1371/journal.pone.0176139)

Anup Sharma, Rajita Vatapalli, Eihab Abdelfatah, Kevin Wyatt McMahon, Zachary Kerner, Angela A. Guzzetta, Jasvinder Singh, Cynthia Zahnow, Stephen B. Baylin, Sashidhar Yerram, Yue Hu, Nilofer Azad, Nita Ahuja

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The following information is missing from the Funding statement: This study was funded by a grant to Dr. Ahuja from Astex Inc. (GRANT # 120039). There is information missing from the Competing Interests statement. The correct Competing Interests statement is as follows: Dr. Ahuja receives research grant funding from Astex Inc. and the Van Andel Research Institute. She is a consultant for and has licensed methylation biomarkers to Cepheid (PATENT # 10167513). Dr. Ahuja has also served as consultant to Johnson and Johnson, an advisor to Celgene, and a member of the Scientific Advisory Council to the No Stomach for Cancer Foundation. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The raw data underlying the findings of this study are missing from the list of Supporting Information. The authors have provided the data as Supporting Information file S1 Data. With this correction [1], all relevant data are now provided.

Original language	English (US)
Article number	e0242750
Journal	PloS one
Volume	15
Issue number	11 November
DOIs	https://doi.org/10.1371/journal.pone.0242750
State	Published - Nov 2020

ASJC Scopus subject areas

General

Access to Document

10.1371/journal.pone.0242750

Cite this

Sharma, A., Vatapalli, R., Abdelfatah, E., McMahon, K. W., Kerner, Z., Guzzetta, A. A., Singh, J., Zahnow, C., Baylin, S. B., Yerram, S., Hu, Y., Azad, N., & Ahuja, N. (2020). Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells (PLoS ONE (2017) 12: 4 (e0176139) DOI: 10.1371/journal.pone.0176139). PloS one, 15(11 November), Article e0242750. https://doi.org/10.1371/journal.pone.0242750

Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells (PLoS ONE (2017) 12: 4 (e0176139) DOI: 10.1371/journal.pone.0176139). / Sharma, Anup; Vatapalli, Rajita; Abdelfatah, Eihab et al.
In: PloS one, Vol. 15, No. 11 November, e0242750, 11.2020.

Research output: Contribution to journal › Comment/debate › peer-review

Sharma, A, Vatapalli, R, Abdelfatah, E, McMahon, KW, Kerner, Z, Guzzetta, AA, Singh, J, Zahnow, C , Baylin, SB, Yerram, S, Hu, Y, Azad, N & Ahuja, N 2020, 'Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells (PLoS ONE (2017) 12: 4 (e0176139) DOI: 10.1371/journal.pone.0176139)', PloS one, vol. 15, no. 11 November, e0242750. https://doi.org/10.1371/journal.pone.0242750

@article{4432603c1fc94fe1b094db8cfc67c60d,

title = "Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells (PLoS ONE (2017) 12: 4 (e0176139) DOI: 10.1371/journal.pone.0176139)",

abstract = "The following information is missing from the Funding statement: This study was funded by a grant to Dr. Ahuja from Astex Inc. (GRANT # 120039). There is information missing from the Competing Interests statement. The correct Competing Interests statement is as follows: Dr. Ahuja receives research grant funding from Astex Inc. and the Van Andel Research Institute. She is a consultant for and has licensed methylation biomarkers to Cepheid (PATENT # 10167513). Dr. Ahuja has also served as consultant to Johnson and Johnson, an advisor to Celgene, and a member of the Scientific Advisory Council to the No Stomach for Cancer Foundation. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The raw data underlying the findings of this study are missing from the list of Supporting Information. The authors have provided the data as Supporting Information file S1 Data. With this correction [1], all relevant data are now provided.",

author = "Anup Sharma and Rajita Vatapalli and Eihab Abdelfatah and McMahon, {Kevin Wyatt} and Zachary Kerner and Guzzetta, {Angela A.} and Jasvinder Singh and Cynthia Zahnow and Baylin, {Stephen B.} and Sashidhar Yerram and Yue Hu and Nilofer Azad and Nita Ahuja",

note = "Publisher Copyright: {\textcopyright} 2020 Sharma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",

year = "2020",

month = nov,

doi = "10.1371/journal.pone.0242750",

language = "English (US)",

volume = "15",

journal = "PloS one",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "11 November",

}

TY - JOUR

T1 - Correction

T2 - Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells (PLoS ONE (2017) 12: 4 (e0176139) DOI: 10.1371/journal.pone.0176139)

AU - Sharma, Anup

AU - Vatapalli, Rajita

AU - Abdelfatah, Eihab

AU - McMahon, Kevin Wyatt

AU - Kerner, Zachary

AU - Guzzetta, Angela A.

AU - Singh, Jasvinder

AU - Zahnow, Cynthia

AU - Baylin, Stephen B.

AU - Yerram, Sashidhar

AU - Hu, Yue

AU - Azad, Nilofer

AU - Ahuja, Nita

N1 - Publisher Copyright: © 2020 Sharma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2020/11

Y1 - 2020/11

N2 - The following information is missing from the Funding statement: This study was funded by a grant to Dr. Ahuja from Astex Inc. (GRANT # 120039). There is information missing from the Competing Interests statement. The correct Competing Interests statement is as follows: Dr. Ahuja receives research grant funding from Astex Inc. and the Van Andel Research Institute. She is a consultant for and has licensed methylation biomarkers to Cepheid (PATENT # 10167513). Dr. Ahuja has also served as consultant to Johnson and Johnson, an advisor to Celgene, and a member of the Scientific Advisory Council to the No Stomach for Cancer Foundation. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The raw data underlying the findings of this study are missing from the list of Supporting Information. The authors have provided the data as Supporting Information file S1 Data. With this correction [1], all relevant data are now provided.

AB - The following information is missing from the Funding statement: This study was funded by a grant to Dr. Ahuja from Astex Inc. (GRANT # 120039). There is information missing from the Competing Interests statement. The correct Competing Interests statement is as follows: Dr. Ahuja receives research grant funding from Astex Inc. and the Van Andel Research Institute. She is a consultant for and has licensed methylation biomarkers to Cepheid (PATENT # 10167513). Dr. Ahuja has also served as consultant to Johnson and Johnson, an advisor to Celgene, and a member of the Scientific Advisory Council to the No Stomach for Cancer Foundation. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The raw data underlying the findings of this study are missing from the list of Supporting Information. The authors have provided the data as Supporting Information file S1 Data. With this correction [1], all relevant data are now provided.

UR - http://www.scopus.com/inward/record.url?scp=85097038262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85097038262&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0242750

DO - 10.1371/journal.pone.0242750

M3 - Comment/debate

C2 - 33253231

AN - SCOPUS:85097038262

SN - 1932-6203

VL - 15

JO - PloS one

JF - PloS one

IS - 11 November

M1 - e0242750

ER -

Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells (PLoS ONE (2017) 12: 4 (e0176139) DOI: 10.1371/journal.pone.0176139)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this